Rationale and Design of Two Phase 3 Randomized Controlled Trials (evolution RMS 1&2) Evaluating the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis (4071)
NEUROLOGY（2020）
关键词
Tyrosine Kinase Inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要